Halberd (Halberd) Dividend Yield % : 0.00% (As of Jun. 03, 2024)

View and export this data going back to 2009. Start your Free Trial

What is Halberd Dividend Yield %?

As of today (2024-06-03), the Trailing Annual Dividend Yield of Halberd is 0.00%.

The historical rank and industry rank for Halberd's Dividend Yield % or its related term are showing as below:

HALB's Dividend Yield % is not ranked ^*
in the Biotechnology industry.
Industry Median: 1.56
* Ranked among companies with meaningful Dividend Yield % only.

Halberd's Dividend Payout Ratio for the six months ended in Jul. 2023 was 0.00.

As of today (2024-06-03), the Forward Dividend Yield % of Halberd is 0.00%.

Halberd's Dividends per Share for the six months ended in Jul. 2023 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Halberd Dividend Yield % Historical Data

The historical data trend for Halberd's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd Dividend Yield % Chart

Halberd Annual Data

Trend

Jul08

Jul22

Jul23

Dividend Yield %

Halberd Semi-Annual Data
	Jul08	Jul22	Jul23
Dividend Yield %	-	-	-

Competitive Comparison of Halberd's Dividend Yield %

For the Biotechnology subindustry, Halberd's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Halberd's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Halberd's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Halberd's Dividend Yield % falls into.

Halberd Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Halberd (OTCPK:HALB) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Halberd Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Halberd's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Halberd (Halberd) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

P.O. Box 25, Jackson Center, PA, USA, 16133

Website

https://www.halberdcorporation.com

Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.

Executives

John Christopher Maddox	director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO	10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist	director, 10 percent owner, officer: CEO, Secretary and Director	24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr.	director	50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas	director	280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236